259 related articles for article (PubMed ID: 2138669)
1. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
Bhargava HN; Gulati A
J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669
[TBL] [Abstract][Full Text] [Related]
2. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats.
Reddy PL; Veeranna ; Thorat SN; Bhargava HN
Brain Res; 1993 Apr; 607(1-2):293-300. PubMed ID: 8481804
[TBL] [Abstract][Full Text] [Related]
4. Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat.
Gudehithlu KP; Reddy PL; Bhargava HN
Brain Res; 1994 Mar; 639(2):269-74. PubMed ID: 7911390
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic administration of morphine and its withdrawal on the rat brain and spinal cord dopamine D1 receptors.
Bhargava HN; Gulati A
Prog Clin Biol Res; 1990; 328():307-10. PubMed ID: 2304954
[No Abstract] [Full Text] [Related]
6. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
Bhargava HN; Gulati A; Ramarao P
Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
Bhargava HN; Gulati A
Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
[TBL] [Abstract][Full Text] [Related]
9. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
Bergman J; Madras BK; Spealman RD
J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
[TBL] [Abstract][Full Text] [Related]
11. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
12. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors.
Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K
Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
Neisewander JL; Lucki I; McGonigle P
J Pharmacol Exp Ther; 1991 May; 257(2):850-60. PubMed ID: 2033524
[TBL] [Abstract][Full Text] [Related]
14. Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats.
Gulati A; Bhargava HN
Eur J Pharmacol; 1989 Aug; 167(2):185-92. PubMed ID: 2591474
[TBL] [Abstract][Full Text] [Related]
15. Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats.
Bhargava HN; Gulati A; Rahmani NH
Eur J Pharmacol; 1991 Sep; 202(3):403-8. PubMed ID: 1660817
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
17. Spinal cord thyrotropin releasing hormone receptors of morphine tolerant-dependent and abstinent rats.
Rahmani NH; Gulati A; Bhargava HN
Peptides; 1990; 11(4):693-5. PubMed ID: 2172939
[TBL] [Abstract][Full Text] [Related]
18. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
19. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
Bhargava HN; Das S; Bansinath M; Prasad R
Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
[TBL] [Abstract][Full Text] [Related]
20. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
Neisewander JL; Ong A; McGonigle P
Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
